The Anti-Tumor Effect of HDAC Inhibition in a Human Pancreas Cancer Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2

Pancreatic ductal adenocarcinoma is the fourth leading cause of cancer death worldwide, with no satisfactory treatment to date. In this study, we tested whether the combined inhibition of cyclooxygenase-2 (COX-2) and class I histone deacetylase (HDAC) may results in a better control of pancreatic du...

Descripción completa

Detalles Bibliográficos
Autores principales: Peulen, Olivier, Gonzalez, Arnaud, Peixoto, Paul, Turtoi, Andrei, Mottet, Denis, Delvenne, Philippe, Castronovo, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770617/
https://www.ncbi.nlm.nih.gov/pubmed/24040391
http://dx.doi.org/10.1371/journal.pone.0075102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770617/
https://www.ncbi.nlm.nih.gov/pubmed/24040391
http://dx.doi.org/10.1371/journal.pone.0075102

Ejemplares similares